Our product portfolio consists of 16 prescription medicines, all for the treatment of human immunodeficiency virus (HIV). These medicines may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries.
Please note that we are unable to provide detailed information about prescription medicines on this website in compliance with UK regulations.
You can find local information by clicking the button below and selecting your country of residence which will take you to your country specific website if available.
If you are a Healthcare Professional looking for information on ViiV Healthcare products, click the button below and select your country of residence.
▼Denotes that this medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. Please see the right hand tool bar for instructions on how to report a side effect.
|Triumeq||dolutegravir/ abacavir/ lamivudine|
|Epzicom/ Kivexa||abacavir/ lamivudine|
|Trizivir||abacavir/ lamivudine/ zidovudine|
Date of preparation: November 2021